Vanessa Stevens

Vanessa Stevens, PhD

Languages spoken: English

Academic Information

Departments Primary - Internal Medicine , Adjunct - Pediatrics , Adjunct - Population Health Sciences

Divisions: , Epidemiology

Academic Office Information

vanessa.stevens@hsc.utah.edu

Education History

Doctoral Training University of Rochester School of Medicine and Dentistry
 PhD
University of Rochester College of Arts and Sciences
 BS

Selected Publications

Journal Article

  1. Bolender CM, Jimenez A, Clarke JT, Willson TM, Stevens VW, Rhoads JLW (2023). Incidence of Dermatomyositis in a Nationwide Cohort Study of US Veterans. JAMA Dermatol, 158(11), 1321-1323.
  2. Levy AG, Thorpe A, Scherer LD, Scherer AM, Drews FA, Butler JM, Burpo N, Shoemaker H, Stevens V, Fagerlin A (2022). Misrepresentation and Nonadherence Regarding COVID-19 Public Health Measures. JAMA Netw Open, 5(10), e2235837.
  3. Gawron LM, He T, Lewis L, Fudin H, Callegari LS, Turok DK, Stevens V (2022). Oral Emergency Contraception Provision in the Veterans Health Administration: a Retrospective Cohort Study. J Gen Intern Med.
  4. Thorpe A, Fagerlin A, Butler J, Stevens V, Drews FA, Shoemaker H, Riddoch MS, Scherer LD (2022). Communicating about COVID-19 vaccine development and safety. PLoS One, 17(8), e0272426.
  5. Thorpe A, Fagerlin A, Drews FA, Butler J, Stevens V, Riddoch MS, Scherer LD (2022). Communications to Promote Interest and Confidence in COVID-19 Vaccines. Am J Health Promot, 36(6), 976-986.
  6. Jasper AS, Musuuza JS, Tischendorf JS, Stevens VW, Gamage SD, Osman F, Safdar N (2019). Are Fluoroquinolones or Macrolides Better for Treating Legionella Pneumonia? A Systematic Review and Meta-analysis. Clin Infect Dis, 72(11), 1979-1989.
  7. Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress AP (2021). Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans. PLoS One, 16(4), e0248080.
  8. Derington CG, Colantonio LD, Herrick JS, Cook J, King JB, Rosenson RS, Poudel B, Monda KL, Navar AM, Mues KE, Stevens VW, Nelson RE, Vanneman ME, Muntner P, Bress AP (2021). Factors Associated With PCSK9 Inhibitor Initiation Among US Veterans. J Am Heart Assoc, 10(8), e019254.
  9. Peterson KS, Lewis J, Patterson OV, Chapman AB, Denhalter DW, Lye PA, Stevens VW, Gamage SD, Roselle GA, Wallace KS, Jones M (2021). Automated Travel History Extraction From Clinical Notes for Informing the Detection of Emergent Infectious Disease Events: Algorithm Development and Validation. JMIR Public Health Surveill, 7(3), e26719.
  10. Khader K, Thomas A, Stevens V, Visnovsky L, Nevers M, Toth D, Keegan LT, Jones M, Rubin M, Samore MH (2021). Association Between Contact Precautions and Transmission of Methicillin-Resistant Staphylococcus aureus in Veterans Affairs Hospitals. JAMA Netw Open, 4(3), e210971.
  11. Jones BE, Ying J, Nevers M, Alba PR, He T, Patterson OV, Jones MM, Stevens V, Shen J, Humpherys J, Peterson KS, Rutter ED, Gundlapalli AV, Weir CR, Dean NC, Fine MJ, Samore MC, Greene TH (2021). Computerized Mortality Prediction for Community-acquired Pneumonia at 117 VA Medical Centers. Ann Am Thorac Soc, 18(7), 1175-1184.
  12. Rhoads JLW, Willson TM, Sutton JD, Spivak ES, Samore MH, Stevens VW (2019). Epidemiology, Disposition, and Treatment of Ambulatory Veterans With Skin and Soft Tissue Infections. Clin Infect Dis, 72(4), 675-681.
  13. Nelson RE, Lautenbach E, Chang N, Jones M, Willson T, David M, Linkin D, Glick H, Doshi JA, Stevens VW (2020). Attributable Cost of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infection in a Long-term Care Center. Clin Infect Dis, 72(Suppl 1), S27-S33.
  14. Khader K, Munoz-Price LS, Hanson R, Stevens V, Keegan LT, Thomas A, Pezzin LE, Nattinger A, Singh S, Samore MH (2020). Transmission Dynamics of Clostridioides difficile in 2 High-Acuity Hospital Units. Clin Infect Dis, 72(Suppl 1), S1-S7.
  15. Nelson RE, Goto M, Samore MH, Jones M, Stevens VW, Evans ME, Schweizer ML, Perencevich EN, Rubin MA (2020). Expanding an Economic Evaluation of the Veterans Affairs (VA) Methicillin-resistant Staphylococcus aureus (MRSA) Prevention Initiative to Include Prevention of Infections From Other Pathogens. Clin Infect Dis, 72(Suppl 1), S50-S58.
  16. Khader K, Thomas A, Huskins WC, Stevens V, Keegan LT, Visnovsky L, Samore MH (2020). Effectiveness of Contact Precautions to Prevent Transmission of Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci in Intensive Care Units. Clin Infect Dis, 72(Suppl 1), S42-S49.
  17. Christensen MA, Nevers M, Ying J, Haroldsen C, Stevens V, Jones MM, Yarbrough PM, Goetz MB, Restrepo MI, Madaras-Kelly K, Samore MH, Jones BE (2020). Simulated Adoption of 2019 Community-Acquired Pneumonia Guidelines Across 114 Veterans Affairs Medical Centers: Estimated Impact on Culturing and Antibiotic Selection in Hospitalized Patients. Clin Infect Dis, 72(Suppl 1), S59-S67.
  18. Stevens VW, Russo EM, Young-Xu Y, Leecaster M, Zhang Y, Zhang C, Yu H, Cai B, Gonzalez EN, Gerding DN, Lawrence J, Samore MH (2020). Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials. Vaccine, 39(3), 536-544.
  19. Dieringer TD, Furukawa D, Graber CJ, Stevens VW, Jones MM, Rubin MA, Goetz MB (2020). Inpatient antibiotic utilization in the Veterans' Health Administration during the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol, 42(6), 1-3.
  20. Sutton JD, Stevens VW, Chang NN, Khader K, Timbrook TT, Spivak ES (2020). Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source. JAMA Netw Open, 3(10), e2020166.
  21. Stevens VW, Khader K, Echevarria K, Nelson RE, Zhang Y, Jones M, Timbrook TT, Samore MH, Rubin MA (2019). Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci. Clin Infect Dis, 71(3), 645-651.
  22. Stevens VW, Shoemaker HE, Jones MM, Jones BE, Nelson RE, Khader K, Samore MH, Rubin MA (2020). Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with Clostridioides difficile infection. Infect Control Hosp Epidemiol, 41(5), 510-516.
  23. Jones BE, Ying J, Stevens V, Haroldsen C, He T, Nevers M, Christensen MA, Nelson RE, Stoddard GJ, Sauer BC, Yarbrough PM, Jones MM, Goetz MB, Greene T, Samore MH (2020). Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia. JAMA Intern Med, 180(4), 552-560.
  24. Khader K, Thomas A, Jones M, Toth D, Stevens V, Samore MH, CDC Modeling Infectious Diseases in Healthcare Program MInD-Healthcare (2019). Variation and trends in transmission dynamics of Methicillin-resistant Staphylococcus aureus in veterans affairs hospitals and nursing homes. Epidemics, 28, 100347.
  25. Stevens VW, Stenehjem DD, Patterson OV, Kamauu AWC, Yim YM, Morlock RJ, DuVall SL (2018). Characterization and survival of patients with metastatic basal cell carcinoma in the Department of Veterans Affairs: a retrospective electronic health record review. Arch Dermatol Res, 310(6), 505-513.
  26. Stenehjem DD, Au T, Sainski AM, Bauer H, Brown K, Lancaster J, Stevens V, Brixner DI (2018). Impact of a genetic counseling requirement prior to genetic testing. BMC Health Serv Res, 18(1), 165.
  27. Cheng Y, Nickman NA, Jamjian C, Stevens V, Zhang Y, Sauer B, LaFleur J (2018). Predicting poor adherence to antiretroviral therapy among treatment-naïve veterans infected with human immunodeficiency virus. Medicine (Baltimore), 97(2), e9495.
  28. Cheng Y, Sauer B, Zhang Y, Nickman NA, Jamjian C, Stevens V, LaFleur J (2018). Adherence and virologic outcomes among treatment-naïve veteran patients with human immunodeficiency virus type 1 infection. Medicine (Baltimore), 97(2), e9430.
  29. Nelson RE, Deka R, Khader K, Stevens VW, Schweizer ML, Rubin MA (2017). Dynamic transmission models for economic analysis applied to health care-associated infections: A review of the literature. Am J Infect Control, 45(12), 1382-1387.
  30. Brown KA, Daneman N, Jones M, Nechodom K, Stevens V, Adler FR, Goetz MB, Mayer J, Samore M (2017). The Drivers of Acute and Long-term Care Clostridium difficile Infection Rates: A Retrospective Multilevel Cohort Study of 251 Facilities. Clin Infect Dis, 65(8), 1282-1288.
  31. Khadem T, Stevens V, Holt K, Hoffmann C, Dumyati G, Brown J (2017). Risk factors for carbapenem-nonsusceptible Pseudomonas aeruginosa: Case-control study. Diagn Microbiol Infect Dis, 89(2), 146-150.
  32. Nelson RE, Slayton RB, Stevens VW, Jones MM, Khader K, Rubin MA, Jernigan JA, Samore MH (2017). Attributable Mortality of Healthcare-Associated Infections Due to Multidrug-Resistant Gram-Negative Bacteria and Methicillin-Resistant Staphylococcus Aureus. Infect Control Hosp Epidemiol, 38(7), 848-856.
  33. Stevens VW, Nelson RE, Schwab-Daugherty EM, Khader K, Jones MM, Brown KA, Greene T, Croft LD, Neuhauser M, Glassman P, Goetz MB, Samore MH, Rubin MA (2017). Comparative Effectiveness of Vancomycin and Metronidazole for the Prevention of Recurrence and Death in Patients With Clostridium difficile Infection. JAMA Intern Med, 177(4), 546-553.
  34. Brown KA, Jones M, Daneman N, Adler FR, Stevens V, Nechodom KE, Goetz MB, Samore MH, Mayer J (2016). Importation, Antibiotics, and Clostridium difficile Infection in Veteran Long-Term Care: A Multilevel Case-Control Study. Ann Intern Med, 164(12), 787-94.
  35. Schwab EM, Wilkes J, Korgenski K, Hersh AL, Pavia AT, Stevens VW (2016). Risk Factors for Recurrent Clostridium difficile Infection in Pediatric Inpatients. Hosp Pediatr, 6(6), 339-44.
  36. Nelson RE, Stevens VW, Khader K, Jones M, Samore MH, Evans ME, Douglas Scott R 2nd, Slayton RB, Schweizer ML, Perencevich EL, Rubin MA (2016). Economic Analysis of Veterans Affairs Initiative to Prevent Methicillin-Resistant Staphylococcus aureus Infections. Am J Prev Med, 50(5 Suppl 1), S58-S65.
  37. Brown KA, Daneman N, Stevens VW, Zhang Y, Greene TH, Samore MH, Arora P (2016). Integrating Time-Varying and Ecological Exposures into Multivariate Analyses of Hospital-Acquired Infection Risk Factors: A Review and Demonstration. Infect Control Hosp Epidemiol, 37(4), 411-9.
  38. Nelson RE, Jones M, Leecaster M, Samore MH, Ray W, Huttner A, Huttner B, Khader K, Stevens VW, Gerding D, Schweizer ML, Rubin MA (2016). An Economic Analysis of Strategies to Control Clostridium Difficile Transmission and Infection Using an Agent-Based Simulation Model. PLoS One, 11(3), e0152248.
  39. Unni SK, Schauerhamer MB, Deka R, Tyczynski JE, Fernandes AW, Stevens V, Brixner DI, Stenehjem DD (2016). BRCA testing, treatment patterns and survival in platinum-sensitive recurrent ovarian cancer - an observational cohort study. J Ovarian Res, 9, 18.
  40. Stevens VW, Thurm C, Schwab EM, Kronman MP, Gerber JS, Shah SS, Newland JG, Courter J, Parker S, Brogan TV, Hersh AL (2016). Use of Concomitant Antibiotics During Treatment for Clostridium difficile Infection (CDI) in Pediatric Inpatients: An Observational Cohort Study. Infect Dis Ther, 5(1), 45-51.